Ian Ellis

About Ian Ellis

Having spent 35 years practicing pathology, Ian Ellis is internationally renowned for his work in clinical and translational research in breast disease – particularly in its classification, molecular pathology, and prognostic factors. He has over 500 peer-reviewed publications and has served as president of the Pathological Society of Great Britain and Ireland and chairman of the UK National Coordinating Committee for Breast Pathology. He’s also been a specialty advisor to the Royal College of Pathologists, the World Health Organization, the UK Department of Health, the Union for International Cancer Control, and the International Agency for Research on Cancer. In addition, he has founded a specialist laboratory service, PathLore, and serves as medical director of Source Bioscience plc. “I hope that histopathology embraces the emerging areas of molecular pathology and patient focused precision medicine going forward,” he says. “Histopathologists are best placed to handle the range of emerging assays required for therapeutic management of patients in a single coordinated, integrated report.”